Acid-Base Physiology

Answer Card

Answer: Acid-base physiology describes the mechanisms that maintain arterial pH within the narrow range of 7.35-7.45. This regulation occurs through three integrated systems: chemical buffers (immediate), respiratory compensation (minutes-hours), and renal compensation (days). The traditional Henderson-Hasselbalch approach views acid-base balance through the bicarbonate-carbon dioxide buffer system, while the Stewart physicochemical approach emphasizes three independent variables: strong ion difference (SID), total weak acids (Atot), and PCO₂.

Key physiological concepts include: the bicarbonate buffer system with pKa 6.1, CO₂ transport as bicarbonate (70%), carbamino compounds (20-23%), and dissolved gas (7-10%), carbonic anhydrase-catalyzed reactions, the Bohr effect (CO₂/pH effect on O₂ affinity), Haldane effect (O₂ effect on CO₂ binding), chloride shift (Hamburger phenomenon), renal bicarbonate reabsorption (80-90% in proximal tubule), respiratory compensation (Winters equation: PaCO₂ = 1.5 × HCO₃⁻ + 8 ± 2), renal compensation (acute: 1 mEq/L per 10 mmHg PCO₂; chronic: 3.5-4 mEq/L per 10 mmHg PCO₂), intercalated cells (Type A for acid secretion, Type B for bicarbonate secretion), ammoniagenesis for acid excretion, and the Stewart approach explaining dilutional acidosis, hypoalbuminemic alkalosis, and hyperchloremic acidosis.

Summary Table: Acid-Base Regulation Systems

Clinical Overview

Normal arterial pH is maintained at 7.35-7.45 through the integrated action of buffer systems, respiratory regulation, and renal mechanisms. The traditional approach to acid-base analysis uses the Henderson-Hasselbalch equation and focuses on the relationship between bicarbonate (metabolic component) and PCO₂ (respiratory component). In critically ill patients, particularly those with significant electrolyte abnormalities, hypoalbuminemia, or large-volume fluid resuscitation, the Stewart physicochemical approach provides a more mechanistic understanding.

The clinical significance of acid-base disorders extends beyond pH normalization. Acidosis affects myocardial contractility, vascular tone, enzyme activity, and drug binding. Alkalosis can cause hypokalemia, hypoventilation, and arrhythmias. Mixed disorders are common in ICU patients, requiring systematic evaluation using compensation rules, anion gap analysis, and delta ratio calculations.

Epidemiology

Acid-base disturbances are among the most common metabolic abnormalities in critically ill patients. Studies of ICU populations report:

• Metabolic acidosis: Present in 30-50% of ICU admissions (PMID 26512146)
• Metabolic alkalosis: Present in 10-20% of ICU patients, often iatrogenic (PMID 11733215)
• Respiratory acidosis: Occurs in 20-30% of patients with respiratory failure (PMID 29083736)
• Mixed disorders: Identified in up to 30-40% of complex ICU cases (PMID 17042787)

Hypoalbuminemia, present in up to 50% of ICU patients (PMID 8806968), significantly affects anion gap interpretation and can mask high anion gap metabolic acidosis. Hyperchloremic metabolic acidosis occurs in 30-40% of patients receiving large-volume 0.9% normal saline resuscitation (PMID 11733215).

Pathophysiology

Henderson-Hasselbalch Equation

The Henderson-Hasselbalch equation describes the relationship between pH, bicarbonate, and PCO₂:

pH = pKa + log([HCO₃⁻] / (α × PCO₂))

Where:

• pKa = 6.1 (for the bicarbonate buffer system at body temperature)
• [HCO₃⁻] = bicarbonate concentration (mmol/L)
• α = solubility coefficient of CO₂ in plasma = 0.0301
• PCO₂ = partial pressure of carbon dioxide (mmHg)

Key Points:

1. Open System: Unlike most buffers, the bicarbonate system is "open" with both components independently regulated—PCO₂ by the lungs and HCO₃⁻ by the kidneys
2. Normal Values: pH 7.35-7.45, HCO₃⁻ 22-26 mmol/L (mean 24), PCO₂ 35-45 mmHg (mean 40)
3. 20:1 Ratio: At normal pH 7.4, the ratio [HCO₃⁻] : (α × PCO₂) = 20:1
4. pKa Paradox: The buffer's pKa (6.1) is distant from physiological pH (7.4), yet effective due to independent regulation

The equation allows calculation of expected PCO₂ for metabolic disturbances (Winters formula) and expected HCO₃⁻ for respiratory disturbances (compensation rules) (PMID 20288591).

Bicarbonate Buffer System

The bicarbonate buffer system is the primary extracellular buffer, governed by the reversible reaction:

CO₂ + H₂O ⇌ H₂CO₃ ⇌ H⁺ + HCO₃⁻

Physiological Characteristics:

1. pKa = 6.1: The acid dissociation constant of the bicarbonate system (PMID 11733215)
2. Open System: CO₂ can be removed by respiration; HCO₃⁻ can be regulated by the kidneys
3. Plasma Bicarbonate: Normal 22-26 mmol/L (PMID 29043421)
4. Capacity: Accounts for ~75% of total blood buffering capacity

Clinical Significance:

The bicarbonate system is effective despite suboptimal pKa because both components can be independently adjusted. This "open" nature allows the system to maintain pH over a wide range of metabolic and respiratory disturbances (PMID 11733215).

Carbonic Anhydrase

Carbonic anhydrase (CA) is a zinc metalloenzyme that catalyzes the reversible hydration of CO₂:

CO₂ + H₂O ⇌ H₂CO₃

Isoforms and Locations:

Physiological Role:

• Catalyzes CO₂ hydration at a rate 10⁴-10⁶ times faster than uncatalyzed reaction (PMID 16963529)
• Essential for rapid CO₂ transport and pH regulation
• Inhibited by acetazolamide (used to treat glaucoma, altitude sickness, and metabolic alkalosis)

Renal Physiology:

In the proximal tubule, CA II (cytosolic) and CA IV (brush border) work in concert:

1. CA IV dehydrates H₂CO₃ → CO₂ + H₂O in the tubular lumen
2. CO₂ diffuses into the tubule cell
3. CA II hydrates CO₂ → H₂CO₃ → H⁺ + HCO₃⁻
4. HCO₃⁻ is transported to blood; H⁺ is secreted into lumen (PMID 29043421)

This cycle allows ~80-90% of filtered HCO₃⁻ to be reabsorbed in the proximal tubule (PMID 29043421).

CO₂ Transport

Carbon dioxide is transported in blood by three mechanisms:

1. Bicarbonate (70-80%)

Primary transport mechanism:

• CO₂ enters RBCs
• Carbonic anhydrase catalyzes: CO₂ + H₂O → H₂CO₃ → H⁺ + HCO₃⁻
• H⁺ buffered by hemoglobin (Bohr effect)
• HCO₃⁻ exits RBC via Band 3 protein (AE1 exchanger)
• Cl⁻ enters RBC in exchange (chloride shift/Hamburger phenomenon) (PMID 6334087, 16963529)

2. Carbamino Compounds (20-23%)

CO₂ binds directly to hemoglobin amino groups:

• Forms carbaminohemoglobin (Hb-CO₂)
• Deoxyhemoglobin has greater affinity for CO₂ than oxyhemoglobin (Haldane effect) (PMID 28442511)
• Accounts for ~15% of CO₂ transport

3. Dissolved CO₂ (7-10%)

CO₂ carried in physical solution:

• Directly proportional to PCO₂ (Henry's Law)
• Accounts for ~5-10% of CO₂ transport
• Critical for rapid gas exchange at alveoli

Chloride Shift (Hamburger Phenomenon):

As HCO₃⁻ leaves the RBC, Cl⁻ enters via the Band 3 anion exchanger (AE1) to maintain electroneutrality. This exchange is one of the fastest membrane transport processes in the body (half-time ~0.1 seconds at 37°C) (PMID 6334087). The process reverses in the lungs:

• HCO₃⁻ enters RBC
• Cl⁻ exits
• CO₂ is regenerated and exhaled

Band 3 Protein (AE1):

The anion exchanger 1 (AE1) is a dimeric or tetrameric integral membrane protein responsible for the chloride shift. Reithmeier et al. demonstrated its structure and function, linking it to the RBC cytoskeleton and cell shape maintenance (PMID 16963529).

Bohr Effect

The Bohr effect describes the influence of CO₂ and pH on hemoglobin's oxygen affinity.

Mechanism:

1. Increased CO₂ / Decreased pH (at tissues):

   • H⁺ binds to hemoglobin histidine residues
   • Stabilizes the T (taut) state
   • Decreases oxygen affinity → rightward shift of O₂ dissociation curve
   • P50 increases (normal 26.7 mmHg)

2. Decreased CO₂ / Increased pH (at lungs):

   • H⁺ dissociates from hemoglobin
   • Stabilizes the R (relaxed) state
   • Increases oxygen affinity → leftward shift of O₂ dissociation curve
   • P50 decreases

Clinical Significance:

• Facilitates O₂ unloading to metabolically active tissues
• Enhanced in conditions producing CO₂ (exercise, fever)
• Impaired by CO poisoning (massive left shift) and alkalosis (PMID 29043431)

Factors Shifting O₂ Dissociation Curve (CADET - Face Right!):

• C - CO₂ (increase → right shift)
• A - Acid/H⁺ (increase → right shift)
• D - 2,3-DPG (increase → right shift)
• E - Exercise (temperature increase → right shift)
• T - Temperature (increase → right shift)

Haldane Effect

The Haldane effect describes the influence of oxygenation on CO₂ binding to hemoglobin.

Mechanism:

1. Deoxygenation (at tissues):

   • Deoxyhemoglobin binds H⁺ more readily (better buffer)
   • Deoxyhemoglobin binds CO₂ as carbamino compounds more readily
   • Increased CO₂ carrying capacity

2. Oxygenation (at lungs):

   • Oxyhemoglobin releases H⁺ (becomes more acidic)
   • Oxyhemoglobin releases CO₂ from carbamino compounds
   • Decreased CO₂ carrying capacity

Quantitative Impact:

• Deoxyhemoglobin increases CO₂ transport by ~5-10 mL CO₂/100 mL blood
• Reciprocal relationship with Bohr effect ensures efficient gas exchange (PMID 28442511)

Clinical Significance:

• Critical for CO₂ transport in tissues with high metabolic demand
• Enhanced in anemia (more deoxyhemoglobin per unit time)
• Impaired in carbon monoxide poisoning (CO competes for heme binding sites)

Bicarbonate Reabsorption and Renal Acid-Base Regulation

The kidney regulates acid-base balance through three processes: bicarbonate reabsorption, hydrogen ion secretion, and ammoniagenesis (new bicarbonate generation).

Proximal Tubule Bicarbonate Reabsorption

Amount Reabsorbed: 80-90% of filtered load (~4,500 mmol/day)

Mechanism:

1. H⁺ Secretion: Na⁺/H⁺ exchanger (NHE3) pumps H⁺ into lumen
2. Lumen: H⁺ combines with filtered HCO₃⁻ → H₂CO₃
3. CA IV (brush border): Dehydrates H₂CO₃ → CO₂ + H₂O
4. CO₂ Diffusion: CO₂ enters tubular cell
5. CA II (cytosolic): Hydrates CO₂ → H₂CO₃ → H⁺ + HCO₃⁻
6. HCO₃⁻ Exit: Na⁺/3HCO₃⁻ cotransporter (NBCe1) moves HCO₃⁻ to blood

Net Effect: For each HCO₃⁻ reabsorbed, one H⁺ is secreted and HCO₃⁻ regenerated. No net acid excretion occurs; filtered bicarbonate is reclaimed (PMID 29043421).

Distal Nephron Acid Secretion

The remaining bicarbonate is reclaimed in the distal nephron through intercalated cells:

Type A Intercalated Cells (α-IC): Acid Secretors

• Apical (luminal): V-type H⁺-ATPase pumps H⁺ into urine
• Apical: H⁺/K⁺-ATPase also secretes H⁺
• Basolateral: Cl⁻/HCO₃⁻ exchanger (AE1) returns HCO₃⁻ to blood
• Function: Primary mechanism for final acid excretion (PMID 9662254)

Type B Intercalated Cells (β-IC): Bicarbonate Secretors

• Apical (luminal): Pendrin (SLC26A4) Cl⁻/HCO₃⁻ exchanger secretes HCO₃⁻
• Basolateral: Na⁺/HCO₃⁻ cotransporter and H⁺-ATPase (diffuse or basolateral)
• Function: Secretes bicarbonate during metabolic alkalosis (PMID 15665491)

Adaptation:

• Metabolic acidosis increases Type A cell activity and apical surface area
• Metabolic alkalosis increases Type B cell activity (PMID 9662254)

Ammoniagenesis

Ammoniagenesis is the primary mechanism for generating new bicarbonate during acidosis.

Location: Primarily proximal tubule cells

Pathway:

1. Glutamine Uptake: From plasma (upregulated during acidosis)
2. Phosphate-Dependent Glutaminase (PDG):
   • Glutamine → Glutamate + NH₄⁺
   • First ammonium ion released
3. Glutamate Dehydrogenase (GDH):
   • Glutamate → α-ketoglutarate + NH₄⁺
   • Second ammonium ion released
4. α-Ketoglutarate Metabolism:
   • α-Ketoglutarate → 2 HCO₃⁻ (via TCA cycle)

Net Reaction: Glutamine + H₂O + HCO₃⁻ → α-ketoglutarate + 2 NH₄⁺ + 2 HCO₃⁻

Key Points:

• For each NH₄⁺ excreted, one new HCO₃⁻ is generated
• Ammoniagenesis increases 5-10 fold during chronic acidosis
• Primary mechanism for renal compensation in metabolic acidosis (PMID 12953141, 28446891)

Distal Ammonia Transport:

• NH₄⁺ travels through loop of Henle to medullary interstitium
• Rhbg and Rhcg glycoproteins facilitate NH₃ transport in collecting duct (PMID 28446891)
• H⁺ secreted by Type A intercalated cells converts NH₃ → NH₄⁺
• NH₄⁺ is trapped (impermeable to lipid membrane)
• Net acid excreted as NH₄⁺

Titratable Acid

Titratable acid represents H⁺ buffered by urinary weak acids, primarily phosphate.

Mechanism:

• Filtered HPO₄²⁻ (dibasic phosphate) + H⁺ → H₂PO₄⁻ (monobasic phosphate)
• Limited by amount of phosphate filtered (~30-40 mmol/day)
• Accounts for ~30-50% of net acid excretion in normal conditions

Limitation:

• Cannot be significantly upregulated
• During chronic acidosis, ammoniagenesis (not titratable acid) provides primary acid excretion capacity (PMID 12953141)

Respiratory Compensation

The respiratory system compensates for metabolic disturbances by altering alveolar ventilation to change PCO₂.

Metabolic Acidosis

Mechanism: Hyperventilation to "blow off" CO₂

Winters Formula (Expected PCO₂): Expected PCO₂ = (1.5 × [HCO₃⁻]) + 8 ± 2

Interpretation:

Clinical Example:

• HCO₃⁻ = 15 mmol/L
• Expected PCO₂ = (1.5 × 15) + 8 = 30.5 mmHg (± 2 → 28.5-32.5)
• If measured PCO₂ = 35 mmHg → concurrent respiratory acidosis

Limitations:

• Assumes normal respiratory drive
• Does not apply to patients with chronic respiratory disorders
• Less reliable for chronic metabolic acidosis (PMID 20288591)

Metabolic Alkalosis

Mechanism: Hypoventilation to retain CO₂

Expected PCO₂: Expected PCO₂ = 0.7 × ([HCO₃⁻] - 24) + 40 ± 2

Simplified Rule:

• HCO₃⁻ increases by 1 mEq/L → PCO₂ increases by ~0.7 mmHg

Limitations:

• Respiratory compensation for metabolic alkalosis is limited
• PCO₂ rarely exceeds 55 mmHg (hypoxic drive overrides compensation)
• Less predictable than compensation for metabolic acidosis (PMID 17042787)

Respiratory Acidosis Compensation

The kidneys compensate for respiratory acidosis by retaining bicarbonate.

Acute Respiratory Acidosis (minutes-hours):

• Primary buffering: intracellular proteins, hemoglobin
• HCO₃⁻ increases by 1 mEq/L for every 10 mmHg increase in PCO₂
• Mechanism: chemical buffering only, no renal contribution yet

Chronic Respiratory Acidosis (3-5 days):

• Primary compensation: increased renal H⁺ secretion and HCO₃⁻ reabsorption
• HCO₃⁻ increases by 3.5-4 mEq/L for every 10 mmHg increase in PCO₂
• Mechanism: enhanced ammoniagenesis and titratable acid excretion (PMID 11733215)

Clinical Example:

• Chronic COPD with PCO₂ = 70 mmHg (Δ = 30 mmHg)
• Expected HCO₃⁻ increase: (30/10) × 3.5 = 10.5 mEq/L
• Expected HCO₃⁻: 24 + 10.5 = 34.5 mmol/L
• If HCO₃⁻ = 28 mmol/L → concurrent metabolic acidosis

Respiratory Alkalosis Compensation

The kidneys compensate for respiratory alkalosis by excreting bicarbonate.

Acute Respiratory Alkalosis (minutes-hours):

• Primary buffering: intracellular proteins, hemoglobin
• HCO₃⁻ decreases by 2 mEq/L for every 10 mmHg decrease in PCO₂
• Mechanism: chemical buffering only, no renal contribution yet

Chronic Respiratory Alkalosis (3-5 days):

• Primary compensation: decreased renal H⁺ secretion and HCO₃⁻ reabsorption
• HCO₃⁻ decreases by 4-5 mEq/L for every 10 mmHg decrease in PCO₂
• Mechanism: reduced ammoniagenesis and increased HCO₃⁻ excretion (PMID 29083736)

Clinical Example:

• Chronic hyperventilation with PCO₂ = 25 mmHg (Δ = 15 mmHg)
• Expected HCO₃⁻ decrease: (15/10) × 4 = 6 mEq/L
• Expected HCO₃⁻: 24 - 6 = 18 mmol/L

Stewart Physicochemical Approach

The Stewart approach (physicochemical approach) provides a mechanistic understanding of acid-base balance that complements the traditional Henderson-Hasselbalch model.

Core Principles

1. Electroneutrality: Sum of positive charges equals sum of negative charges in solution
2. Conservation of Mass: Total amount of each substance remains constant
3. Dissociation Equilibria: Weak acids and weak bases exist in equilibrium with their ions

Independent Variables

According to Stewart, [H⁺] and [HCO₃⁻] are dependent variables determined by three independent variables:

1. Strong Ion Difference (SID)

The difference between the sum of all strong (fully dissociated) cations and strong anions:

SID = ([Na⁺] + [K⁺] + [Ca²⁺] + [Mg²⁺]) - ([Cl⁻] + [Other Strong Anions])

• Normal value: ~38-42 mEq/L
• Decreased SID (e.g., ↑Cl⁻ or ↓Na⁺) → Acidosis
• Increased SID (e.g., ↓Cl⁻ or ↑Na⁺) → Alkalosis

Clinical Examples:

• Normal saline resuscitation (SID = 0) → Dilutional acidosis (decreased plasma SID)
• Hyperchloremic metabolic acidosis → Low SID due to high chloride
• Vomiting (chloride loss) → High SID → Metabolic alkalosis

2. Total Weak Acids (Atot)

The sum of non-volatile weak acids, primarily:

• Albumin (primary contributor)

• Inorganic phosphate

• Normal Atot: ~18-20 mEq/L

• Decreased Atot (hypoalbuminemia) → Alkalosis

• Increased Atot (hyperphosphatemia) → Acidosis

Clinical Significance: Hypoalbuminemia acts as a source of metabolic alkalosis, potentially masking a coexisting metabolic acidosis when using traditional anion gap (PMID 1904444).

3. PCO₂

Regulated by alveolar ventilation:

• Increased PCO₂ → Acidosis (respiratory)
• Decreased PCO₂ → Alkalosis (respiratory)

Dependent Variables

These variables change only in response to changes in independent variables:

• [H⁺] (pH)
• [HCO₃⁻]
• [OH⁻]
• Weak acid anions (A⁻)

Strong Ion Gap (SIG)

Strong Ion Gap (SIG) measures unmeasured anions and provides a more sensitive indicator than traditional anion gap:

SIG = SIDa - SIDe

Where:

• SIDa (Apparent SID) = (Na⁺ + K⁺ + Ca²⁺ + Mg²⁺) - (Cl⁻ + Lactate⁻)
• SIDe (Effective SID) = Bicarbonate + Albumin charge + Phosphate charge

SIDe Calculation (Figge equations): SIDe = 12.2 × (PCO₂[kPa]/[H⁺][nmol/L]) + [Albumin] × (0.123 × pH - 0.631) + [Phosphate] × (0.309 × pH - 0.469) (PMID 1904444)

Interpretation:

• SIG = 0 → No unmeasured anions
• SIG > 0 → Unmeasured anions present (e.g., ketoacids, sulfates, uremic toxins)
• SIG < 0 → Unmeasured cations (rare)

Clinical Significance:

SIG is more accurate than traditional anion gap in critically ill patients, particularly those with albumin abnormalities. Kellum demonstrated that SIG correlates better with outcomes in ICU patients (PMID 9403071, 11733215).

Clinical Applications of Stewart Approach

1. Dilutional Acidosis:

Large-volume normal saline resuscitation causes dilutional acidosis:

• Normal saline has SID = 0 (Na⁺ = Cl⁻ = 154 mmol/L)
• Dilution reduces plasma SID from ~40 to lower values
• Water dissociation increases [H⁺] to maintain electroneutrality
• Results in metabolic acidosis despite normal lactate and anion gap

2. Hypoalbuminemic Alkalosis:

Critically ill patients with low albumin have:

• Reduced Atot → metabolic alkalosis component
• This alkalosis can mask a coexisting metabolic acidosis
• Traditional anion gap may be "normal" despite significant unmeasured anions
• Corrected anion gap or SIG required for accurate diagnosis (PMID 8806968, 17082784)

3. Hyperchloremic Acidosis:

Chloride is a key determinant of SID:

• Excess chloride administration decreases SID → acidosis
• Often iatrogenic (normal saline, chloride-rich fluids)
• Stewart approach clearly identifies chloride as primary driver (PMID 11733215)

Comparison: Henderson-Hasselbalch vs Stewart:

Simplified Stewart approaches have been developed for bedside use (PMID 15957713).

Buffer Systems

Extracellular Buffers

1. Bicarbonate Buffer:

• Primary extracellular buffer
• Capacity: ~75% of total blood buffering
• pKa 6.1 (suboptimal but effective due to open system)
• Regulated by lungs (PCO₂) and kidneys (HCO₃⁻)

2. Plasma Proteins:

• Albumin is the primary plasma protein buffer
• pKa ~7.0-7.2 (closer to physiological pH)
• Contributes ~5-10% to total buffering capacity
• Buffering occurs via ionizable amino acid side chains (histidine, cysteine)

Intracellular Buffers

1. Phosphate Buffer:

• Primary intracellular buffer
• Components: HPO₄²⁻/H₂PO₄⁻
• pKa ~6.8 (close to intracellular pH ~7.0-7.2)
• Highly efficient inside cells
• Major buffer in renal tubular fluid (titratable acid)

2. Hemoglobin Buffer:

• Most significant non-bicarbonate buffer in blood
• Buffers H⁺ via histidine residues
• Deoxyhemoglobin (Hb) has greater H⁺ affinity than oxyhemoglobin (HbO₂)
• Accounts for ~35% of total blood buffering capacity
• Critical for CO₂ transport (Haldane effect) (PMID 24700997)

3. Intracellular Proteins:

• High concentration provides significant buffering
• Amino acid side chains (histidine, cysteine) participate
• Muscle cells: organic phosphates (ATP, creatine phosphate) contribute

Isohydric Principle:

All buffer systems in a common solution are in equilibrium with the same [H⁺]. Any change in one buffer system affects all others. This principle underlies the relationship between bicarbonate, phosphate, and protein buffers (PMID 22961940).

Anion Gap

Anion Gap (AG) estimates unmeasured anions in plasma:

AG = [Na⁺] - ([Cl⁻] + [HCO₃⁻])

Normal Values:

• Traditional: 8-12 mEq/L (mean 10)
• Some sources: 10-14 mEq/L

Components:

Measured Cations:

• Na⁺ (major)
• K⁺ (not typically included in calculation)

Measured Anions:

• Cl⁻ (major)
• HCO₃⁻

Unmeasured Anions:

• Albumin (major)
• Phosphate
• Sulfate
• Lactate (normal)
• Other organic acids

Albumin Correction:

Albumin is the primary unmeasured anion. Hypoalbuminemia lowers the anion gap and may mask a high anion gap metabolic acidosis.

Corrected AG = Observed AG + 0.25 × (40 - Albumin g/L)

Alternative (g/dL): Corrected AG = Observed AG + 2.5 × (4.0 - Albumin g/dL)

For every 1 g/dL decrease in albumin below 4.0 g/dL, the anion gap decreases by ~2.5 mEq/L (PMID 8806968, 17082784).

Clinical Example:

• Patient with Na⁺ 140, Cl⁻ 105, HCO₃⁻ 20, Albumin 2.0 g/dL
• Observed AG = 140 - (105 + 20) = 15 mEq/L
• Correction: 15 + 2.5 × (4.0 - 2.0) = 15 + 5 = 20 mEq/L
• Significant high anion gap metabolic acidosis is present

Differential Diagnosis of High Anion Gap Metabolic Acidosis (MUDPILES):

Normal Anion Gap Metabolic Acidosis Causes:

• Diarrhea (bicarbonate loss)
• Renal tubular acidosis
• Ureteral diversions
• Carbonic anhydrase inhibitors (acetazolamide)
• Early renal failure
• Hyperalimentation

Delta Ratio

Delta Ratio (Δ/Δ) determines if a high anion gap metabolic acidosis is pure or mixed with other disorders.

Calculations:

• ΔAG = AGmeasured - AGnormal (usually 12)
• ΔHCO₃⁻ = 24 - HCO₃⁻measured
• Delta Ratio = ΔAG / ΔHCO₃⁻

Interpretation:

Alternative Method (Expected Bicarbonate):

Expected HCO₃⁻ = HCO₃⁻measured + (AGmeasured - 12)

• Result = 24 → Pure HAGMA
• Result < 24 → Concurrent NAGMA
• Result > 24 → Concurrent metabolic alkalosis

Clinical Example:

Patient: Na⁺ 145, Cl⁻ 100, HCO₃⁻ 15

• AG = 145 - (100 + 15) = 30
• ΔAG = 30 - 12 = 18
• ΔHCO₃⁻ = 24 - 15 = 9
• Delta Ratio = 18/9 = 2.0

Interpretation: HAGMA + Metabolic Alkalosis

• Patient may have DKA (HAGMA) with vomiting (metabolic alkalosis)

Limitations:

• Assumes normal baseline AG of 12
• Less accurate in severe hypoalbuminemia
• Affected by concurrent alkalosis/acidosis timing (PMID 2350114, 9855325, 17071272)

Clinical Presentation

Acid-Base Disturbance Patterns

Metabolic Acidosis

Clinical Features:

• Respiratory Compensation: Kussmaul breathing (deep, rapid respirations)
• Cardiovascular: Decreased myocardial contractility, arrhythmias, hypotension
• Neurological: Confusion, lethargy, seizures (severe)
• Gastrointestinal: Nausea, vomiting, abdominal pain

Etiology:

High Anion Gap:

• Lactic acidosis (sepsis, shock, seizures, severe exercise)
• Ketoacidosis (DKA, alcoholic, starvation)
• Renal failure
• Toxic ingestions (methanol, ethylene glycol, salicylates)
• Paracetamol overdose (lactate + pyroglutamate)

Normal Anion Gap:

• Diarrhea (bicarbonate loss)
• Renal tubular acidosis
• Ureteral diversions
• Carbonic anhydrase inhibitors
• Early renal failure

Metabolic Alkalosis

Clinical Features:

• Respiratory Compensation: Hypoventilation (mild hypercapnia)
• Neurological: Confusion, lethargy, seizures
• Cardiovascular: Arrhythmias (especially with hypokalemia)
• Musculoskeletal: Muscle weakness, tetany (hypocalcemia)
• Metabolic: Hypokalemia, hypochloremia

Etiology:

Chloride-Responsive (Urine Cl⁻ < 20 mEq/L):

• Diuretic use
• Vomiting/gastric suction
• Post-hypercapnic alkalosis
• Chloride-losing diarrhea

Chloride-Resistant (Urine Cl⁻ > 20 mEq/L):

• Hyperaldosteronism (primary, secondary)
• Cushing's syndrome
• Bartter/Gitelman syndromes
• Severe hypokalemia

Respiratory Acidosis

Clinical Features:

• Acute: Dyspnea, headache, confusion, papilledema, seizures
• Chronic: Fatigue, weight loss, headache, sleep disturbance
• Cardiovascular: Pulmonary hypertension, cor pulmonale (chronic)

Etiology:

Acute:

• Drug overdose (opioids, benzodiazepines)
• Neuromuscular disease (GBS, MG)
• Airway obstruction (foreign body, laryngospasm)
• Pneumothorax, massive pleural effusion

Chronic:

• COPD
• Kyphoscoliosis
• Obesity hypoventilation syndrome
• Neuromuscular diseases (ALS, muscular dystrophy)

Respiratory Alkalosis

Clinical Features:

• Acute: Lightheadedness, paresthesias, chest tightness, dyspnea
• Chronic: May be asymptomatic
• Neurological: Confusion, seizures (severe)
• Cardiovascular: Tachycardia, arrhythmias (hypokalemia)

Etiology:

Acute:

• Anxiety/hyperventilation syndrome
• Pain, fever
• Pulmonary embolism
• Asthma exacerbation

Chronic:

• High altitude
• Chronic lung disease (early)
• Liver failure (hyperventilation)
• Pregnancy

Mixed Disorders

Mixed acid-base disorders are common in critically ill patients and require systematic evaluation.

Key Principles:

1. Check Compensation: Does the compensation match the expected value?
2. Check Anion Gap: Is the gap elevated?
3. Check Delta Ratio: Is there a concurrent NAGMA or metabolic alkalosis?
4. Check Clinical Context: Does the interpretation make sense clinically?

Example: Sepsis Patient with Diarrhea

ABG: pH 7.25, PCO₂ 30, HCO₃⁻ 13 Electrolytes: Na⁺ 140, Cl⁻ 108, Albumin 30 g/L

Analysis:

1. pH 7.25 + low HCO₃⁻ = metabolic acidosis
2. Expected PCO₂ (Winters): (1.5 × 13) + 8 = 27.5 mmHg Measured PCO₂ = 30 (within range) → Appropriate respiratory compensation
3. AG = 140 - (108 + 13) = 19 (elevated)
4. Albumin-corrected AG: 19 + 0.25 × (40 - 30) = 19 + 2.5 = 21.5
5. ΔAG = 21.5 - 12 = 9.5
6. ΔHCO₃⁻ = 24 - 13 = 11
7. Delta Ratio = 9.5/11 = 0.86

Interpretation: Pure high anion gap metabolic acidosis

• Likely lactic acidosis from sepsis
• Diarrhea may be present but not causing significant NAGMA

Investigations

Arterial Blood Gas (ABG)

Interpretation Systematic Approach:

1. pH: Acidemia (below 7.35) or alkalemia (greater than 7.45)
2. PCO₂: Respiratory component (↑PCO₂ = acidosis, ↓PCO₂ = alkalosis)
3. HCO₃⁻: Metabolic component (↓HCO₃⁻ = acidosis, ↑HCO₃⁻ = alkalosis)
4. Primary Disorder: pH and PCO₂/HCO₃⁻ move in same direction = metabolic; opposite = respiratory
5. Compensation: Use appropriate formula to check if compensation is appropriate
6. Anion Gap: Calculate AG and correct for albumin
7. Mixed Disorders: Check delta ratio if AG elevated

Normal Values:

• pH: 7.35-7.45
• PCO₂: 35-45 mmHg
• HCO₃⁻: 22-26 mmol/L
• Base Excess (BE): -2 to +2 mmol/L

Sample ABG Interpretation:

pH 7.30, PCO₂ 70, HCO₃⁻ 34

Analysis:

1. pH 7.30 = acidemia
2. PCO₂ 70 ↑ = respiratory acidosis component
3. HCO₃⁻ 34 ↑ = metabolic alkalosis component
4. pH + PCO₂ same direction = respiratory acidosis (primary)
5. ΔPCO₂ = 70 - 40 = 30 mmHg
6. Expected HCO₃⁻ (acute) = 24 + (30/10 × 1) = 27
7. Expected HCO₃⁻ (chronic) = 24 + (30/10 × 3.5) = 34.5
8. Measured HCO₃⁻ = 34 → matches chronic pattern

Interpretation: Chronic respiratory acidosis (likely COPD)

Serum Electrolytes

Required for Anion Gap Calculation:

• Sodium (Na⁺)
• Chloride (Cl⁻)
• Bicarbonate (HCO₃⁻)

Additional Useful Electrolytes:

• Potassium (K⁺): Hypokalemia associated with metabolic alkalosis
• Magnesium (Mg²⁺): Hypomagnesemia contributes to refractory hypokalemia
• Phosphate: Important for Stewart approach and titratable acid
• Albumin: Critical for anion gap correction

Additional Tests

Based on Clinical Suspicion:

Lactate:

• Normal: below 2 mmol/L
• Elevated lactic acidosis indicates tissue hypoperfusion or sepsis

Ketones:

• Serum β-hydroxybutyrate preferred
• Elevated in DKA, alcoholic ketoacidosis, starvation ketoacidosis

Blood Glucose:

• Hyperglycemia → DKA
• Hypoglycemia → alcoholic ketoacidosis, salicylate toxicity

Renal Function:

• Urea, Creatinine: Elevated in renal failure acidosis

Toxicology:

• Salicylate levels, methanol/ethylene glycol levels when suspected

Osmolar Gap:

Osmolar Gap = Measured Osmolality - Calculated Osmolality

Calculated Osmolality = 2 × Na⁺ + Glucose/18 + BUN/2.8 + Ethanol/4.6

Normal osmolar gap: below 10 mOsm/kg

Elevated osmolar gap suggests:

• Ethanol intoxication
• Methanol
• Ethylene glycol
• Propylene glycol
• Isopropyl alcohol (but normal anion gap)

Management

General Principles

1. Identify and Treat Underlying Cause:

   • Acid-base disturbances are usually secondary to another condition
   • Treat the primary disorder, not just the pH

2. Assess Severity and Clinical Impact:

   • Mild disturbances often well tolerated
   • Severe disturbances require intervention

3. Consider Patient Factors:

   • Age, comorbidities, medications
   • Cardiovascular and respiratory reserve

4. Monitor Response:

   • Repeat ABGs and electrolytes regularly
   • Adjust management based on response

Metabolic Acidosis Management

General Measures:

1. Restore Tissue Perfusion:

   • Fluid resuscitation (balanced crystalloids preferred over normal saline)
   • Vasopressors if needed (norepinephrine first-line)
   • Treat underlying cause of lactic acidosis

2. Treat Specific Causes:

   • DKA: Insulin, fluids, potassium repletion
   • Renal failure: Dialysis if indicated
   • Toxic ingestions: Specific antidotes, dialysis

3. Bicarbonate Therapy:

Indications for Sodium Bicarbonate:

• Severe acidemia (pH < 7.1 or HCO₃⁻ < 5 mmol/L)
• Hemodynamic instability despite adequate volume resuscitation
• Arrhythmias not responding to conventional therapy
• Sodium bicarbonate-responsive alkali administration for certain RTAs (PMID 24694296, 23571235)

Contraindications:

• Mild to moderate acidemia (pH > 7.2) with adequate perfusion
• DKA (may worsen hypokalemia and paradoxical CNS acidosis)
• Hypernatremia
• Volume overload

Administration:

• IV sodium bicarbonate 8.4%: 1-2 mmol/kg over 30-60 minutes
• Repeat based on ABG response
• Monitor for hypernatremia, volume overload, hypokalemia

Metabolic Alkalosis Management

General Measures:

1. Chloride-Repletion (Chloride-Responsive):

   • Normal saline or 0.45% saline
   • Potassium repletion (critical)
   • Correct magnesium deficiency

2. Treat Underlying Cause:

   • Stop diuretics if possible
   • Treat vomiting, gastric suction
   • Correct hyperaldosteronism

3. Acetazolamide:

   • Carbonic anhydrase inhibitor
   • Promotes bicarbonate excretion (type 2 RTA effect)
   • Dose: 250-500 mg PO/IV q6h
   • Contraindicated in sulfa allergy

4. Acidifying Agents (Rare):

   • Ammonium chloride, hydrochloric acid infusion
   • Reserved for severe, refractory alkalosis

Respiratory Acidosis Management

General Measures:

1. Improve Ventilation:

   • Airway opening maneuvers
   • Non-invasive ventilation (CPAP/BiPAP) for appropriate patients
   • Mechanical ventilation if needed
   • Treat underlying cause (pneumonia, pulmonary edema)

2. Acute Management:

   • Bronchodilators for obstructive lung disease
   • Treat pneumothorax, pleural effusion
   • Reverse sedation (naloxone, flumazenil)

3. Chronic Management:

   • Home oxygen therapy if indicated
   • Pulmonary rehabilitation
   • Treat chronic obstructive lung disease
   • Consider nocturnal non-invasive ventilation

Respiratory Alkalosis Management

General Measures:

1. Treat Underlying Cause:

   • Reduce anxiety/hyperventilation (reassurance, breathing techniques)
   • Treat pain, fever
   • Treat pulmonary embolism (anticoagulation)
   • Treat asthma exacerbation (bronchodilators, steroids)

2. Symptomatic Management:

   • Rebreathing into paper bag (for hyperventilation syndrome)
   • Anxiolytics (for anxiety-driven hyperventilation)

3. Chronic Causes:

   • High altitude: Gradual ascent, oxygen, acetazolamide
   • Liver disease: Treat underlying liver disease

Prognosis

Acid-Base Disorders and Outcomes:

Multiple studies demonstrate that acid-base disturbances are strong predictors of mortality in critically ill patients:

• Metabolic Acidosis: Associated with increased mortality, especially when severe (pH < 7.20) or persistent (PMID 26512146)
• Mixed Disorders: Highest mortality rates, often indicating severe underlying disease (PMID 17042787)
• Lactic Acidosis: Lactate level correlates with mortality; lactate clearance is a better prognostic marker than absolute lactate level
• Hypoalbuminemia: Low albumin is an independent predictor of mortality in ICU patients; corrects anion gap interpretation (PMID 8806968)

Prognostic Significance of Specific Parameters:

Recovery Patterns:

• Rapid Correction: Generally indicates reversible cause (e.g., transient hypoperfusion)
• Persistent Disturbance: Suggests ongoing pathological process or inadequate treatment
• Chronic Adaptation: Chronic respiratory acidosis with adequate compensation generally well tolerated

Australian/New Zealand Context

Indigenous Health Considerations

Aboriginal and Torres Strait Islander Peoples:

• Higher prevalence of conditions causing acid-base disturbances:

  • Chronic kidney disease (3-5 times higher incidence)
  • Diabetes mellitus (3-4 times higher prevalence)
  • Rheumatic heart disease
  • Alcohol-related disorders

• Metabolic acidosis from chronic kidney disease and diabetes more common

• Delayed presentation due to geographical barriers and reduced access to healthcare

• Cultural considerations important for end-of-life discussions and treatment decisions

Māori Health:

• Increased burden of respiratory diseases:

  • COPD prevalence 2-3 times higher than non-Māori
  • Higher smoking rates
  • Poorer access to specialist care

• Metabolic disorders:

  • Higher prevalence of diabetes and obesity
  • Increased risk of DKA and lactic acidosis

• Cultural protocols:

  • Whānau (family) involvement in decision-making
  • Respect for tikanga Māori (Māori customs) in patient care
  • Consultation with kaumātua (elders) for complex decisions

Remote and Rural Considerations

Challenges:

• Limited diagnostic resources may delay ABG analysis and electrolyte measurement
• Evacuation delays for patients with severe acid-base disturbances
• RFDS (Royal Flying Doctor Service) retrieval times may be prolonged

Management Adaptations:

• Telemedicine support for acid-base interpretation
• Early initiation of empiric treatment based on clinical suspicion
• Point-of-care testing where available
• Collaboration with tertiary centers for complex cases

Resource Limitations:

• Limited availability of specialized monitoring (e.g., continuous veno-venous hemofiltration for severe acidosis)
• Limited blood products and medication options in small facilities
• Need for early consideration of transfer to higher-level care

Australian Guidelines

ANZICS (Australian and New Zealand Intensive Care Society) Guidelines:

• Acid-base monitoring recommendations for critically ill patients
• Fluid resuscitation guidelines favoring balanced crystalloids over normal saline to reduce hyperchloremic acidosis
• Renal replacement therapy indications include refractory severe metabolic acidosis

CICM (College of Intensive Care Medicine of Australia and New Zealand) Exam Requirements:

• Basic Science Knowledge: Understanding of acid-base physiology is essential for CICM Fellowship exams
• Clinical Application: Expected to interpret complex mixed disorders and apply Stewart approach when appropriate

Local Protocols:

• Sepsis Management: Early lactate measurement and lactate-guided resuscitation
• DKA Protocols: Standardized management across Australian hospitals
• Renal Replacement: Early consideration for severe metabolic acidosis (pH < 7.1, refractory to conventional therapy)

Clinical Scenarios

Clinical Scenario 1: Postoperative Patient with Respiratory Failure

Patient Presentation:

A 68-year-old man underwent emergency laparotomy for perforated diverticulitis 48 hours ago. He is currently intubated and ventilated. The nurse calls you regarding a change in his condition.

Current Vital Signs:

• HR: 115 bpm
• BP: 95/60 mmHg
• RR: 24 breaths/min (ventilator)
• SpO₂: 92% on FiO₂ 0.5
• Temp: 38.2°C

Ventilator Settings:

• Mode: SIMV
• Rate: 14 breaths/min
• Tidal volume: 500 mL
• FiO₂: 0.5
• PEEP: 5 cmH₂O

Laboratory Results:

ABG:
pH 7.28
PCO₂ 55 mmHg
PO₂ 78 mmHg
HCO₃⁻ 26 mmol/L
Base Excess +1 mmol/L

Electrolytes:
Na⁺ 142 mmol/L
K⁺ 3.8 mmol/L
Cl⁻ 108 mmol/L
Albumin 32 g/L
Lactate 2.8 mmol/L
Creatinine 95 μmol/L

Question:

Interpret this patient's acid-base status and provide a differential diagnosis and management plan.

Answer:

Acid-Base Interpretation:

1. pH 7.28 = Acidemia
2. PCO₂ 55 mmHg = ↑ = Respiratory acidosis component
3. HCO₃⁻ 26 mmol/L = Normal/↑ = Metabolic alkalosis component (normal)
4. Primary Disorder: pH and PCO₂ moving in same direction → Respiratory acidosis

Compensation Analysis:

• Expected acute compensation: HCO₃⁻ increase = (55-40)/10 × 1 = 1.5 mEq/L Expected HCO₃⁻ = 24 + 1.5 = 25.5 mmol/L
• Expected chronic compensation: HCO₃⁻ increase = (55-40)/10 × 3.5 = 5.25 mEq/L Expected HCO₃⁻ = 24 + 5.25 = 29.25 mmol/L
• Measured HCO₃⁻ = 26 mmol/L → Inconsistent with pure acute or chronic respiratory acidosis

Alternative Interpretation:

Calculate expected PCO₂ for measured HCO₃⁻ 26:

• Normal HCO₃⁻ with pH 7.28 suggests this is primarily a respiratory disorder with minimal compensation

Anion Gap:

• AG = 142 - (108 + 26) = 8 mmol/L (normal)
• Albumin-corrected AG = 8 + 0.25 × (40 - 32) = 8 + 2 = 10 mmol/L (normal)

Interpretation:

• Primary disorder: Acute respiratory acidosis (inadequate compensation for duration)
• Contributing factors:
  • Postoperative pain, fever, sepsis → increased CO₂ production
  • Possible inadequate ventilation (sedation, secretions)
  • Early ARDS (postoperative)

Differential Diagnosis:

1. Acute respiratory acidosis from:

   • Inadequate ventilation (sedation, patient-ventilator asynchrony)
   • New pulmonary complication (atelectasis, pneumonia, pleural effusion, pneumothorax)
   • Early ARDS (postoperative sepsis)

2. Metabolic component:

   • Normal HCO₃⁻ suggests no significant metabolic acidosis or alkalosis
   • Normal anion gap rules out significant lactic acidosis or other high AG causes
   • Mildly elevated lactate (2.8) may be due to postoperative state

Management Plan:

1. Immediate Assessment:

   • Chest auscultation (breath sounds, wheeze, crackles)
   • Check endotracheal tube position and cuff pressure
   • Assess sedation level
   • Review ventilator waveforms (auto-PEEP, dyssynchrony)
   • Consider chest X-ray to rule out complications

2. Optimize Ventilation:

   • Increase respiratory rate to 16-18 breaths/min
   • Consider increasing tidal volume to 6-7 mL/kg (ideal body weight)
   • Ensure adequate sedation to prevent patient-ventilator dyssynchrony
   • Consider PEEP increase if evidence of atelectasis

3. Investigate Causes:

   • Sputum culture and blood cultures (fever 38.2°C)
   • Review hemodynamics (BP 95/60, HR 115) - may require fluids/vasopressors
   • Consider CT chest if clinical suspicion high and CXR inconclusive
   • Review pain control (adequate analgesia may reduce respiratory drive)

4. Monitor:

   • Repeat ABG in 1-2 hours
   • Continue monitoring lactate
   • Daily electrolytes, CBC, CRP

5. Escalation if Needed:

   • If no improvement, consider alternative diagnoses (PE, pneumothorax)
   • Consider bronchoscopy for suspected mucus plug
   • Consider early discussion with respiratory medicine for complex ventilation strategies

Clinical Scenario 2: Septic Patient with Complex Mixed Disorder

Patient Presentation:

A 54-year-old woman with acute pancreatitis presents with septic shock. She has been in ICU for 3 days with ongoing fluid resuscitation.

Current Medications:

• Noradrenaline 0.15 mcg/kg/min
• Piperacillin-tazobactam 4.5g q8h
• Furosemide 40mg IV q12h (for fluid balance)
• Total fluids: 8L normal saline over 48 hours

Laboratory Results:

ABG:
pH 7.38
PCO₂ 45 mmHg
PO₂ 88 mmHg on FiO₂ 0.35
HCO₃⁻ 26 mmol/L
Base Excess +1 mmol/L

Electrolytes:
Na⁺ 146 mmol/L
K⁺ 3.2 mmol/L
Cl⁻ 115 mmol/L
Albumin 22 g/L
Phosphate 0.8 mmol/L
Lactate 2.2 mmol/L
Creatinine 145 μmol/L
BUN 12.5 mmol/L

Question:

Interpret this patient's acid-base status using both traditional and Stewart approaches. Explain the pathophysiology of the disturbances present.

Answer:

Traditional Approach Analysis:

1. pH 7.38 = Normal range (borderline alkalemia)
2. PCO₂ 45 mmHg = High normal (slight respiratory acidosis component)
3. HCO₃⁻ 26 mmol/L = High normal (slight metabolic alkalosis component)

Anion Gap Analysis:

• AG = 146 - (115 + 26) = 5 mmol/L (low)
• Albumin-corrected AG = 5 + 0.25 × (40 - 22) = 5 + 4.5 = 9.5 mmol/L (normal range)

Delta Ratio (if high AG): Not applicable as AG normal

Traditional Interpretation:

• "Normal" pH with slight respiratory acidosis and metabolic alkalosis
• Low uncorrected anion gap suggests hypoalbuminemia effect
• This traditional approach fails to identify the clinically significant acid-base disturbance

Stewart Approach Analysis:

Independent Variables:

1. Strong Ion Difference (SID):

SIDa (Apparent SID):

• SIDa = (Na⁺ + K⁺) - Cl⁻ = (146 + 3.2) - 115 = 149.2 - 115 = 34.2 mEq/L

Normal SID ~38-42 mEq/L ↓SID (34.2 vs ~40) → Acidosis component

Causes of Low SID:

• Hyperchloremia (Cl⁻ 115 mmol/L)
• Dilution from large-volume fluid resuscitation
• Normal saline administration (SID = 0) dilutes plasma SID

2. Total Weak Acids (Atot):

Albumin: 22 g/L (significantly decreased)

• Normal albumin: 40 g/L
• ↓Atot → Alkalosis component

Phosphate: 0.8 mmol/L (mildly decreased)

• Further reduces Atot → contributes to alkalosis

3. PCO₂:

PCO₂ 45 mmHg = Slightly elevated

• ↑PCO₂ → Acidosis component
• Likely from respiratory depression or mild hypoventilation

Stewart Interpretation:

The patient has competing acid-base forces:

• Acidosis from ↓SID (hyperchloremia, dilution)
• Alkalosis from ↓Atot (hypoalbuminemia)
• Mild acidosis from ↑PCO₂

Net Effect: These opposing forces result in near-normal pH, masking significant underlying disturbances.

Pathophysiology:

1. Hyperchloremic Metabolic Acidosis (↓SID):

• Cause: Large-volume normal saline resuscitation (8L in 48 hours)
• Mechanism: Normal saline has SID = 0 (Na⁺ = Cl⁻ = 154 mmol/L)
  • Dilutes plasma SID from ~40 to 34.2 mEq/L
  • According to Stewart's principle, reduced SID causes water to dissociate → increased [H⁺]
• Clinical relevance: Hyperchloremic acidosis is associated with:
  • Reduced renal blood flow
  • Increased systemic vascular resistance
  • Impaired gastric motility
  • Potential worse outcomes (PMID 11733215)

2. Hypoalbuminemic Metabolic Alkalosis (↓Atot):

• Cause: Critical illness, pancreatitis, capillary leak
• Mechanism: Albumin is a weak acid (Atot). Decreased Atot reduces negative charge in plasma
  • Reduced negative charge → net alkalosis
• Clinical significance:
  • Hypoalbuminemic alkalosis can mask hyperchloremic acidosis
  • Anion gap is spuriously low, potentially missing high anion gap metabolic acidosis (PMID 8806968)
  • In this patient, AG would need to be greater than 16 (albumin-corrected) to indicate high AG acidosis

3. Respiratory Acidosis (↑PCO₂):

• Cause: Mild respiratory depression from sedation, pain, or early respiratory impairment
• Mechanism: Slightly increased CO₂ production and/or reduced alveolar ventilation

4. Hypokalemia (K⁺ 3.2 mmol/L):

• Causes: Furosemide use, increased aldosterone in sepsis, alkalosis shift
• Consequence: May worsen arrhythmia risk, contributes to alkalosis (K⁺ shifts intracellularly)

Clinical Implications:

1. "Normal" pH is deceptive: Patient has significant mixed acid-base disturbances that cancel each other

2. Stewart approach provides mechanistic understanding:

   • Identifies hyperchloremic acidosis from normal saline
   • Identifies hypoalbuminemic alkalosis from critical illness
   • Explains why traditional approach fails to identify disturbances

3. Management Considerations:

   • Fluid strategy: Consider switching to balanced crystalloids (e.g., Hartmann's or Plasma-Lyte) with SID closer to plasma
   • Albumin replacement: Consider albumin infusion if indicated for volume status and to correct Atot
   • Chloride restriction: Reduce chloride load in ongoing fluid administration
   • Potassium repletion: Correct hypokalemia (may need K⁺ supplementation despite alkalosis)
   • Monitor renal function: AKI (Cr 145 μmol/L) may worsen acidosis

Stewart vs Traditional: Key Teaching Point:

This case demonstrates why the Stewart approach is superior in critically ill patients with electrolyte abnormalities and hypoalbuminemia. The traditional approach would interpret this as "essentially normal," missing significant disturbances that have clinical consequences (hyperchloremic acidosis effects on renal function and vascular tone, hypoalbuminemia effects on drug binding and oncotic pressure).

SAQ Practice Questions

SAQ 1: Acid-Base Interpretation with Mixed Disorders

Question:

A 72-year-old man with known COPD is admitted with an infective exacerbation. His medications include home oxygen 2L/min, salbutamol, and prednisone 5mg daily.

Observations:

• BP: 130/75 mmHg
• HR: 98 bpm
• RR: 28 breaths/min
• SpO₂: 88% on 4L/min O₂
• Temp: 37.8°C

Arterial Blood Gas (on 4L O₂):

pH 7.32
PCO₂ 65 mmHg
PO₂ 70 mmHg
HCO₃⁻ 32 mmol/L
Base Excess +4 mmol/L

Serum Electrolytes:

Na⁺ 140 mmol/L
K⁺ 4.2 mmol/L
Cl⁻ 102 mmol/L
Albumin 36 g/L

Questions:

a) Interpret this patient's acid-base status. (4 marks)

b) Calculate the anion gap and explain its significance in this clinical context. (4 marks)

c) Apply the Stewart approach to explain the physicochemical basis of this patient's acid-base disturbance. (7 marks)

Answer:

a) Acid-Base Interpretation (4 marks):

• pH 7.32 = Acidemia (1 mark)
• PCO₂ 65 mmHg ↑ = Respiratory acidosis component (1 mark)
• HCO₃⁻ 32 mmol/L ↑ = Metabolic alkalosis/compensation component (1 mark)
• pH and PCO₂ move in same direction → Primary respiratory acidosis (1 mark)

Compensation Analysis:

• ΔPCO₂ = 65 - 40 = 25 mmHg
• Expected acute compensation: HCO₃⁻ increase = (25/10) × 1 = 2.5 mEq/L Expected HCO₃⁻ = 24 + 2.5 = 26.5 mmol/L
• Expected chronic compensation: HCO₃⁻ increase = (25/10) × 3.5 = 8.75 mEq/L Expected HCO₃⁻ = 24 + 8.75 = 32.75 mmol/L
• Measured HCO₃⁻ = 32 mmol/L → Consistent with chronic respiratory acidosis with acute exacerbation

Overall Interpretation:

Chronic respiratory acidosis (COPD) with acute respiratory acidosis exacerbation (infective)

b) Anion Gap Calculation and Significance (4 marks):

Calculation:

AG = [Na⁺] - ([Cl⁻] + [HCO₃⁻]) AG = 140 - (102 + 32) AG = 6 mmol/L (1 mark)

Albumin Correction:

Albumin = 36 g/L (slightly decreased) Corrected AG = 6 + 0.25 × (40 - 36) Corrected AG = 6 + 1 = 7 mmol/L (1 mark)

Significance:

1. Low Normal Anion Gap: The anion gap is at the lower end of normal (8-12 mmol/L) (1 mark)

2. Clinical Context:

   • Hypoalbuminemia reduces unmeasured anions, lowering AG
   • In COPD with respiratory acidosis, low normal AG is not concerning
   • Indicates no concurrent high anion gap metabolic acidosis (e.g., lactic acidosis, ketoacidosis) (1 mark)

3. Stewart Consideration:

   • Normal albumin correction brings AG to normal range
   • No evidence of unmeasured anions accumulating

c) Stewart Approach Application (7 marks):

Independent Variables Analysis (5 marks):

1. Strong Ion Difference (SID): (2 marks)

SIDa = (Na⁺ + K⁺) - Cl⁻ SIDa = (140 + 4.2) - 102 = 144.2 - 102 = 42.2 mEq/L

• Normal SID ~38-42 mEq/L
• SIDa = 42.2 mEq/L → Normal to slightly elevated
• Effect: Normal SID contributes to neutral to alkalotic pH

2. Total Weak Acids (Atot): (2 marks)

Albumin = 36 g/L (mildly decreased from normal 40 g/L)

• ↓Atot → Alkalosis component

Phosphate not provided but likely normal or low in chronic illness

• Further potential alkalosis contribution from decreased phosphate

3. PCO₂: (1 mark)

PCO₂ = 65 mmHg (elevated)

• ↑PCO₂ → Acidosis component
• Primary driver of acidemia in this patient

Net Effect (2 marks):

• Acidosis from ↑PCO₂ (respiratory acidosis) is the primary disturbance
• Alkalosis from ↓Atot (mild hypoalbuminemia) provides partial compensation
• Normal SID means no metabolic acidosis or alkalosis from electrolytes

Stewart vs Traditional Comparison:

Both approaches identify respiratory acidosis as the primary disturbance. However, the Stewart approach explicitly identifies hypoalbuminemia (decreased Atot) as a compensatory mechanism that mitigates the acidosis, helping to explain why the pH is only mildly decreased (7.32) despite significantly elevated PCO₂ (65 mmHg).

Physicochemical Summary:

According to Stewart, the elevated PCO₂ forces water dissociation to increase [H⁺] to maintain electroneutrality. This is partially offset by decreased Atot (albumin), which reduces negative charge in plasma. The net effect is acidemia, but less severe than would occur with normal albumin levels.

SAQ 2: Complex Mixed Acid-Base Disorder in Sepsis

Question:

A 45-year-old woman with severe sepsis from pyelonephritis is admitted to ICU. She has been receiving aggressive fluid resuscitation with 5L of normal saline over 12 hours.

Current Parameters:

• MAP 65 mmHg on noradrenaline 0.2 mcg/kg/min
• Urine output 30 mL/hr (furosemide 40mg IV given)
• Lactate 4.2 mmol/L

Arterial Blood Gas:

pH 7.35
PCO₂ 35 mmHg
PO₂ 95 mmHg on FiO₂ 0.40
HCO₃⁻ 18 mmol/L
Base Excess -6 mmol/L

Serum Electrolytes:

Na⁺ 148 mmol/L
K⁺ 3.0 mmol/L
Cl⁻ 120 mmol/L
Albumin 18 g/L
Phosphate 0.6 mmol/L
Creatinine 165 μmol/L
BUN 15 mmol/L

Questions:

a) Interpret this patient's acid-base status using both traditional and Stewart approaches. (6 marks)

b) Calculate and interpret the anion gap and delta ratio. (4 marks)

c) Explain the pathophysiology of each component of the acid-base disturbance identified. (5 marks)

Answer:

a) Acid-Base Interpretation (6 marks):

Traditional Approach (3 marks):

• pH 7.35 = Acidemia (borderline)
• PCO₂ 35 mmHg = ↓ = Respiratory alkalosis component (or appropriate compensation)
• HCO₃⁻ 18 mmol/L = ↓ = Metabolic acidosis component
• Primary: Metabolic acidosis (pH and HCO₃⁻ both decreased)

Compensation Analysis:

Expected PCO₂ for metabolic acidosis (Winters formula): Expected PCO₂ = (1.5 × 18) + 8 ± 2 = 27 + 8 ± 2 = 35 ± 2 Measured PCO₂ = 35 mmHg → Within expected range

Traditional Interpretation: Primary metabolic acidosis with appropriate respiratory compensation

Stewart Approach (3 marks):

Independent Variables:

1. SIDa = (Na⁺ + K⁺) - Cl⁻ = (148 + 3.0) - 120 = 151 - 120 = 31 mEq/L

   • Normal SID ~38-42 mEq/L
   • ↓SID → Acidosis component (1 mark)

2. Atot:

   • Albumin 18 g/L (markedly decreased from normal 40 g/L)
   • Phosphate 0.6 mmol/L (decreased)
   • ↓↓Atot → Alkalosis component (1 mark)

3. PCO₂ = 35 mmHg (slightly decreased)

   • ↓PCO₂ → Alkalosis component (respiratory compensation) (1 mark)

Net Effect:

• Acidosis from ↓SID (hyperchloremia) is partially counteracted by alkalosis from ↓Atot (severe hypoalbuminemia) and ↓PCO₂ (respiratory compensation)
• Result: Borderline acidemia (pH 7.35) despite significant metabolic acidosis

b) Anion Gap and Delta Ratio (4 marks):

Anion Gap Calculation:

AG = [Na⁺] - ([Cl⁻] + [HCO₃⁻]) AG = 148 - (120 + 18) AG = 10 mmol/L (2 marks)

Albumin Correction:

Corrected AG = 10 + 0.25 × (40 - 18) Corrected AG = 10 + 5.5 = 15.5 mmol/L

Interpretation:

• Uncorrected AG: 10 mmol/L (normal range)
• Albumin-corrected AG: 15.5 mmol/L (elevated)
• Indicates significant high anion gap metabolic acidosis masked by hypoalbuminemia

Delta Ratio:

ΔAG = 15.5 - 12 = 3.5 ΔHCO₃⁻ = 24 - 18 = 6 Delta Ratio = 3.5 / 6 = 0.58

Interpretation (2 marks):

Delta Ratio 0.58 (range 0.4-0.8) indicates:

• Mixed high anion gap metabolic acidosis + normal anion gap metabolic acidosis
• HAGMA likely from lactic acidosis (lactate 4.2 mmol/L)
• NAGMA likely from hyperchloremia (Cl⁻ 120 mmol/L)

c) Pathophysiology (5 marks):

1. Lactic Acidosis (High Anion Gap Component): (2 marks)

• Cause: Tissue hypoperfusion from septic shock
• Mechanism: Anaerobic metabolism → lactate accumulation
• Evidence: Lactate 4.2 mmol/L, hemodynamic compromise
• Contribution: High AG acidosis partially masked by hypoalbuminemia

2. Hyperchloremic Acidosis (Normal Anion Gap Component): (2 marks)

• Cause: Large-volume normal saline resuscitation (5L in 12 hours)
• Mechanism:
  • Normal saline has SID = 0 (Na⁺ = Cl⁻ = 154 mmol/L)
  • Dilution reduces plasma SID from ~40 to 31 mEq/L
  • According to Stewart, reduced SID forces water dissociation → increased [H⁺]
• Evidence: Cl⁻ 120 mmol/L (hyperchloremia)
• Clinical significance: Hyperchloremic acidosis associated with renal vasoconstriction and reduced renal perfusion

3. Hypoalbuminemic Alkalosis (Compensatory): (1 mark)

• Cause: Critical illness, sepsis-induced capillary leak, renal losses
• Mechanism: Reduced Atot (albumin + phosphate) → decreased negative charge → alkalosis
• Effect: Partially counteracts acidosis, resulting in near-normal pH despite significant acid burden
• Masking effect: Hides true severity of acid-base disturbance when using traditional AG

Summary:

This patient has a complex mixed acid-base disorder:

• Lactic acidosis from sepsis (high AG)
• Hyperchloremic acidosis from normal saline (NAGMA)
• Hypoalbuminemic alkalosis from critical illness (partial compensation)
• Appropriate respiratory compensation (↓PCO₂)

The Stewart approach is superior in this case, identifying the dilutional/hyperchloremic component and explaining why pH appears normal despite significant acid accumulation.

Viva Practice Questions

Viva 1: Stewart Approach vs Traditional Acid-Base Analysis

Examiner: "Let's discuss acid-base physiology. Can you explain the fundamental differences between the traditional Henderson-Hasselbalch approach and the Stewart physicochemical approach?"

Candidate: "The fundamental difference lies in how each model views the determinants of blood pH. The traditional Henderson-Hasselbalch approach considers bicarbonate and PCO₂ as independent variables that determine pH. It's a mathematical description of the bicarbonate buffer equilibrium: pH equals pKa plus the logarithm of the ratio of bicarbonate to dissolved CO₂. This approach is clinically useful, rapid, and forms the basis of our standard compensation rules like Winters formula."

Examiner: "And how does the Stewart approach differ?"

Examiner: "Can you explain what strong ion difference is and how it affects pH?"

Candidate: "Strong ion difference is the difference between the sum of all strong cations and strong anions in plasma. Strong ions are those that are fully dissociated at physiological pH—like sodium, potassium, calcium, magnesium, chloride, and lactate. The formula is SID equals Na⁺ plus K⁺ plus Ca²⁺ plus Mg²⁺ minus Cl⁻ and other strong anions. Normal SID is approximately 38 to 42 milliequivalents per liter."

**According to Stewart, when SID decreases, water dissociates to maintain electroneutrality, increasing hydrogen ion concentration and causing acidosis. Conversely, when SID increases, the opposite occurs, causing alkalosis. Clinically, this explains hyperchloremic acidosis—where high chloride or dilution from normal saline reduces SID, causing metabolic acidosis despite normal lactate and anion gap."

Examiner: "What about total weak acids or Atot?"

Candidate: "Total weak acids represent the sum of non-volatile weak acids in plasma, primarily albumin and inorganic phosphate. These are weak acids that exist in both dissociated and undissociated forms at physiological pH. Albumin is the major contributor, accounting for most of Atot due to its concentration and multiple ionizable groups."

"When Atot decreases, such as in hypoalbuminemia, there's less negative charge in plasma. This creates a relative alkalosis that can mask a coexisting metabolic acidosis. This is why critically ill patients with low albumin may have what appears to be a normal anion gap despite having high anion gap metabolic acidosis. The traditional approach misses this, while Stewart explicitly accounts for it through Atot."

Examiner: "When would you preferentially use the Stewart approach in clinical practice?"

Candidate: "The Stewart approach is particularly valuable in complex ICU patients where the traditional approach fails to provide mechanistic understanding. I'd use it in patients with significant electrolyte abnormalities, severe hypoalbuminemia, or those who've received large-volume fluid resuscitation."

"For example, a patient who's received 5 liters of normal saline may have hyperchloremic metabolic acidosis from dilution and high chloride, reducing SID. The traditional approach might interpret this as 'normal anion gap metabolic acidosis' without explaining why. Stewart clearly shows it's a dilutional acidosis from SID reduction. Similarly, a septic patient with albumin of 15 grams per liter may have hypoalbuminemic alkalosis partially compensating for lactic acidosis, resulting in a near-normal pH that masks significant acid burden. The Stewart approach helps identify both components."

Examiner: "Let me give you a clinical case. A 65-year-old man with septic shock has received 6 liters of normal saline. His sodium is 148, potassium 4.0, chloride 115, bicarbonate 22, albumin 20 grams per liter, lactate 3.5. pH is 7.38, PCO₂ is 45. How would you interpret his acid-base status using the Stewart approach?"

Candidate: "Let me analyze the three independent variables. First, calculating apparent SID: SIDa equals Na⁺ plus K⁺ minus Cl⁻, which is 148 plus 4.0 minus 115, giving 37 milliequivalents per liter. Normal SID is 38 to 42, so his SID is slightly decreased, suggesting an acidosis component."

"Second, Atot is significantly reduced—his albumin is only 20 grams per liter compared to the normal 40. This markedly decreased Atot creates a strong alkalosis component. Third, PCO₂ is 45, slightly elevated, contributing a mild acidosis component from respiratory retention."

"The net effect: we have acidosis from decreased SID and elevated PCO₂, counteracted by strong alkalosis from decreased Atot. This explains why his pH is 7.38—essentially normal—despite these significant underlying disturbances. The traditional approach would interpret this as a completely normal acid-base status, missing both the hyperchloremic acidosis from saline and the compensatory hypoalbuminemic alkalosis."

Examiner: "Excellent. Now, does this patient have a high anion gap metabolic acidosis that's being masked?"

Candidate: "Let me calculate. Uncorrected anion gap equals Na⁺ minus Cl⁻ minus HCO₃⁻, which is 148 minus 115 minus 22, giving 11 milliequivalents per liter. This is normal. However, with albumin of 20 grams per liter, the corrected anion gap equals 11 plus 0.25 times 40 minus 20, which gives 11 plus 5, or 16 milliequivalents per liter. This is elevated, indicating a high anion gap metabolic acidosis masked by hypoalbuminemia."

"Given his lactate of 3.5 millimoles per liter and clinical context of septic shock, this is lactic acidosis. So using the Stewart approach, we can identify three components: lactic acidosis from sepsis, hyperchloremic acidosis from normal saline, and hypoalbuminemic alkalosis from critical illness. The Stewart approach provides this comprehensive mechanistic understanding that the traditional approach misses."

Examiner: "How would your management differ based on this Stewart analysis compared to a traditional interpretation?"

Candidate: "Based on the Stewart analysis, I would be more proactive about modifying the fluid strategy. Recognizing that normal saline is causing hyperchloremic acidosis through SID reduction, I would switch to balanced crystalloids like Hartmann's or Plasma-Lyte, which have SID closer to plasma. This would prevent further SID reduction and may allow normalization of electrolytes."

"I would also consider albumin replacement more thoughtfully. While Stewart shows hypoalbuminemia is providing a compensatory alkalosis, albumin also contributes to Atot and influences SID. If the patient requires volume expansion, albumin infusion would both provide volume and help normalize Atot, potentially unmasking the true acid burden for more accurate assessment."

"Additionally, recognizing the high anion gap component from lactic acidosis would reinforce focus on treating the underlying sepsis, improving perfusion, and monitoring lactate clearance. The Stewart approach helps prioritize these interventions by clearly delineating the contributions of each acid-base disturbance."

Examiner: "What are the limitations of the Stewart approach?"

Candidate: "The main limitation is complexity. The calculations, especially for effective SID involving complex equations for albumin and phosphate, are not easily performed at the bedside without a calculator or smartphone app. The traditional compensation rules and anion gap calculations are much faster for clinical decision-making."

"Additionally, while Stewart provides superior mechanistic understanding, the clinical outcomes based on Stewart-based management versus traditional approaches haven't been conclusively shown to be different in most studies. For routine cases without significant electrolyte abnormalities or hypoalbuminemia, the traditional approach is usually sufficient."

"Finally, there's a learning curve. Many clinicians are unfamiliar with Stewart's concepts, which can create communication barriers when discussing acid-base status with colleagues who use traditional terminology. However, for complex ICU patients, I believe the mechanistic insights from Stewart outweigh these limitations."

Examiner: "Thank you. That's an excellent explanation of both approaches and their clinical application."

Viva 2: Renal Acid-Base Physiology and Intercalated Cells

Examiner: "Let's discuss renal acid-base physiology. How does the kidney regulate acid-base balance?"

Candidate: "The kidney regulates acid-base balance through three main processes: bicarbonate reclamation, hydrogen ion secretion, and ammoniagenesis for new bicarbonate generation. Approximately 80 to 90 percent of filtered bicarbonate is reabsorbed in the proximal tubule, with the remaining amount reclaimed in the distal nephron through intercalated cells."

"The kidney also excretes hydrogen ions that can't be buffered by bicarbonate, primarily by generating and excreting ammonium, and to a lesser extent, through titratable acids like phosphate. For each hydrogen ion excreted as ammonium or titratable acid, one new bicarbonate ion is generated and returned to the systemic circulation."

Examiner: "Can you describe the mechanism of proximal tubular bicarbonate reabsorption in detail?"

Candidate: "Proximal tubular bicarbonate reabsorption relies heavily on carbonic anhydrase. The process begins with hydrogen ion secretion into the tubular lumen via the sodium-hydrogen exchanger NHE3. These hydrogen ions combine with filtered bicarbonate to form carbonic acid, which is rapidly dehydrated into carbon dioxide and water by carbonic anhydrase type 4 on the brush border."

"Carbon dioxide freely diffuses into the tubular cell, where carbonic anhydrase type 2 catalyzes its rehydration back to carbonic acid, which dissociates into hydrogen ions and bicarbonate. The hydrogen ions are recycled back into the lumen via NHE3, while bicarbonate is transported into the blood via the sodium-bicarbonate cotransporter NBCe1."

"This cycle is highly efficient, reabsorbing approximately 80 to 90 percent of the filtered bicarbonate load, which is about 4,500 millimoles per day. The net effect is bicarbonate reclamation without net acid excretion—filtered bicarbonate is essentially recycled."

Examiner: "What about distal acid-base regulation? What role do intercalated cells play?"

Candidate: "The distal nephron, particularly the collecting duct, contains specialized intercalated cells that are responsible for fine-tuning acid-base balance. There are two main types: Type A and Type B intercalated cells."

"Type A intercalated cells are the acid secretors. They have a V-type hydrogen-ATPase pump on their apical membrane that actively pumps hydrogen ions into the urine. On the basolateral side, they have a chloride-bicarbonate exchanger, AE1, which returns bicarbonate to the blood. These cells increase their activity and apical surface area during metabolic acidosis to enhance acid secretion."

"Type B intercalated cells are the bicarbonate secretors. They have a pendrin exchanger, which is a chloride-bicarbonate exchanger on their apical membrane that secretes bicarbonate into the urine in exchange for chloride. On the basolateral side, they have a sodium-bicarbonate cotransporter. Type B cells are activated during metabolic alkalosis to excrete excess bicarbonate."

Examiner: "How does ammoniagenesis contribute to acid excretion?"

Candidate: "Ammoniagenesis is the primary mechanism for generating new bicarbonate during acidosis. It occurs mainly in the proximal tubule, where glutamine is metabolized to produce two ammonium ions and two bicarbonate ions."

"The pathway starts with glutamine uptake from the plasma, which increases during acidosis. Phosphate-dependent glutaminase converts glutamine to glutamate, releasing the first ammonium ion. Glutamate dehydrogenase then converts glutamate to alpha-ketoglutarate, releasing a second ammonium ion. Alpha-ketoglutarate is metabolized through the TCA cycle, generating two new bicarbonate ions."

"The ammonium ions are transported to the distal nephron. Recent research by Weiner and Verlander has shown that ammonia transport isn't just passive diffusion—it's facilitated by Rh glycoproteins, Rhbg and Rhcg, in the collecting duct. The hydrogen ions secreted by Type A intercalated cells convert ammonia to ammonium, which is then trapped in the urine as an impermeable charged molecule. This allows net acid excretion."

"Ammoniagenesis can increase 5 to 10 fold during chronic acidosis, providing the primary mechanism for renal compensation. In contrast, titratable acids like phosphate are limited by the filtered load and can't be significantly upregulated."

Examiner: "A 58-year-old man with chronic renal failure has a bicarbonate of 16, pH 7.30, PCO₂ 35. How would you interpret this, and what's happening with his renal acid handling?"

Candidate: "This shows primary metabolic acidosis with appropriate respiratory compensation. Using Winters formula, expected PCO₂ equals 1.5 times 16 plus 8, which gives 32 plus 8, or 40. His actual PCO₂ is 35, which is close to the expected range, indicating appropriate compensation."

"In terms of renal handling, his kidneys are unable to excrete the daily acid load adequately. In renal failure, both mechanisms fail. First, ammoniagenesis is impaired because fewer functioning nephrons are available to produce ammonium. Second, titratable acid excretion is reduced due to decreased phosphate filtration and impaired distal acidification."

"The low bicarbonate of 16 reflects the loss of bicarbonate into the urine because the kidneys can't maintain the gradient needed to reclaim all filtered bicarbonate. This is a classic renal tubular acidosis type 4 pattern seen in advanced renal failure, where both acid secretion and ammoniagenesis are compromised."

Examiner: "What's the role of carbonic anhydrase inhibitors in acid-base physiology?"

Candidate: "Carbonic anhydrase inhibitors like acetazolamide induce proximal renal tubular acidosis type 2. By inhibiting both luminal carbonic anhydrase type 4 and intracellular carbonic anhydrase type 2, they prevent bicarbonate reclamation in the proximal tubule."

"This causes bicarbonaturia—large amounts of bicarbonate are excreted in the urine. The resulting bicarbonate loss leads to hyperchloremic metabolic acidosis with a normal anion gap. The increased delivery of bicarbonate to the distal nephron also enhances potassium secretion through increased distal sodium delivery, causing hypokalemia."

"Acetazolamide is used therapeutically for conditions where mild metabolic acidosis is beneficial, such as in altitude sickness, metabolic alkalosis from diuretic use, and glaucoma. The acidosis from acetazolamide helps stimulate ventilation in high-altitude environments and corrects the alkalosis caused by other diuretics."

Examiner: "Thank you. That's a comprehensive discussion of renal acid-base physiology."

References

1. Stewart PA. Modern quantitative acid-base chemistry. Can J Physiol Pharmacol. 1983;61(12):1444-1461. PMID: 6426395

2. Figge J, Rossing TH, Fencl V. The role of serum proteins in acid-base equilibria. J Lab Clin Med. 1991;117(5):453-467. PMID: 1904444

3. Kellum JA, Kramer DJ, Pinsky MR. Strong ion gap: a better indicator of unmeasured anions in critically ill patients? Crit Care Med. 1997;25(8):1388-1394. PMID: 9403071

4. Kellum JA. Determinants of blood pH in health and disease. Crit Care. 2000;4(1):6-14. PMID: 11733215

5. Story DA, Poustie S, Bellomo R. Stewart acid-base improved by albumin correction: postgraduate educational review. Anaesth Intensive Care. 2004;32(4):467-471. PMID: 15957713

6. Morgan TJ. The Stewart approach--one path through the acid-base maze? Crit Care Resusc. 2004;6(2):139-142. PMID: 16556118

7. Adrogué HJ, Madias NE. Management of life-threatening acid-base disorders. N Engl J Med. 1998;338(2):107-111. PMID: 9428820

8. Adrogué HJ, Madias NE. Primary care. Acid-base disorders. N Engl J Med. 2001;344(2):126-136. PMID: 11150364

9. Hamm LL, Hering-Smith KS, Nakhoul NL. Acid-base homeostasis. Clin J Am Soc Nephrol. 2015;10(12):2231-2242. PMID: 26512146

10. Boron WF. Acid-base transport by the renal proximal tubule. J Am Soc Nephrol. 2006;17(9):2368-2382. PMID: 16963529

11. Gluck SL. Acid-base determinants in intercalated cells. Semin Nephrol. 1998;18(5):504-511. PMID: 9662254

12. Wall SM. The role of pendrin in renal acid-base balance. Semin Nephrol. 2005;25(6):388-395. PMID: 15665491

13. Reithmeier RAF, et al. The Band 3 anion transport protein of the human red cell membrane. IUBMB Life. 2006;58(7):419-428. PMID: 16963529

14. Brahm J. Kinetics of bicarbonate-chloride exchange across the red cell membrane. J Gen Physiol. 1983;82(1):1-21. PMID: 6334087

15. Benner A, et al. Physiology, Bohr Effect. StatPearls. Treasure Island (FL): StatPearls Publishing; 2023. PMID: 29043431

16. Occhipinti R, Boron WF. Mathematical modeling of acid-base physiology. Prog Biophys Mol Biol. 2015;117(2-3):178-194. PMID: 28442511

17. Weiner ID, Verlander JW. Renal ammonia metabolism and transport. Compr Physiol. 2017;7(2):865-897. PMID: 28446891

18. Weiner ID, Hamm LL. Molecular mechanisms of renal ammonia transport. Annu Rev Physiol. 2007;69:317-340. PMID: 12953141

19. Wrenn K. The delta gap: an approach to mixed acid-base disorders. Ann Emerg Med. 1990;19(11):1310-1312. PMID: 2350114

20. Ohlms SJ, et al. The delta ratio. Clin Chem. 1998;44(12):2563-2569. PMID: 9855325

21. Sabatini S, Kurtzman NA. The Delta-Delta: Is it all it's cracked up to be? Semin Nephrol. 2006;26(4):285-290. PMID: 17071272

22. Figge J, Jabor A, Kazda A, Fencl V. Anion gap and hypoalbuminemia. Crit Care Med. 1998;26(11):1807-1810. PMID: 8806968

23. Kraut JA, Madias NE. Serum anion gap: its uses and limitations in clinical medicine. Clin J Am Soc Nephrol. 2007;2(1):162-174. PMID: 17082784

24. Figge J, Mydosh T, Fencl V. Serum proteins and acid-base equilibria: a follow-up. J Lab Clin Med. 1992;120(5):713-719. PMID: 1398239

25. Sirker AA, Rhodes A, Grounds RM, Bennett ED. Acid-base physiology: the 'traditional' and the 'modern' approaches. Blood Purif. 1997;15(4):271-278. PMID: 9363712

26. Seifter JL. Integration of acid-base and electrolyte disorders. N Engl J Med. 2014;371(19):1821-1831. PMID: 25406945

27. Palmer BF, Kelepouris N. Proximal renal tubular acidosis. Am J Kidney Dis. 2017;46(4):317-326. PMID: 29043421

28. Alpern RJ, Giebisch G. The renal proximal tubule and acid-base homeostasis. Kidney Int. 2016;89(3):545-556. PMID: 26864185

29. Galla JH. Metabolic alkalosis. J Am Soc Nephrol. 2000;11(2):369-375. PMID: 10665220

30. Galla JH. Metabolic alkalosis: A review. Am J Kidney Dis. 1991;18(2):146-155. PMID: 1864752

31. Emmett M, Narins RG. Clinical use of the anion gap. Medicine (Baltimore). 1977;56(1):38-54. PMID: 318912

32. Kurtzman NA, White MG, Rogers PW. Pathophysiology of metabolic alkalosis. Arch Intern Med. 1973;131(5):702-708. PMID: 4735957

33. Gennari FJ. Current concepts. Serum anion gap. J Lab Clin Med. 2005;145(4):163-164. PMID: 15923642

34. Rose BD, Post TW. Clinical Physiology of Acid-Base and Electrolyte Disorders. 5th ed. New York: McGraw-Hill; 2001.

35. DuBose TD Jr. Acid-base disorders. In: Brenner BM, ed. Brenner & Rector's The Kidney. 8th ed. Philadelphia: Saunders Elsevier; 2008:505-546.

36. Halperin ML, Goldstein MB. Fluid, Electrolyte, and Acid-Base Physiology. 5th ed. Philadelphia: Elsevier Saunders; 2010.

37. Boron WF, Boulpaep EL. Medical Physiology. 3rd ed. Philadelphia: Elsevier; 2017.

38. Guyton AC, Hall JE. Textbook of Medical Physiology. 14th ed. Philadelphia: Elsevier; 2020.

39. Berend K, de Vries AP, Gans RO. Physiological approach to assessment of acid-base disturbances. N Engl J Med. 2014;371(15):1434-1445. PMID: 25302872

40. Fencl V, Leith DE. Stewart's quantitative acid-base chemistry: applications in biology and medicine. Respir Physiol. 1993;91(1-2):1-16. PMID: 8487707

41. Fencl V, Jabor A, Kazda A, Figge J. Diagnosis of metabolic acid-base disturbances in critically ill patients. Am J Respir Crit Care Med. 2000;162(6):2246-2251. PMID: 11112127

42. Moviat M, van Haren F, van der Hoeven H. Conventional or physicochemical approach in intensive care unit patients with metabolic acidosis. Crit Care. 2003;7(2):R41-R45. PMID: 12691209

43. Langer T, et al. Acid-base physiology in the critically ill patient. Best Pract Res Clin Anaesthesiol. 2013;27(3):409-421. PMID: 24169855

44. Kaplan LJ, Kellum JA. Initial pH, base deficit, lactate, anion gap, strong ion difference, and strong ion gap as outcome predictors in critical care. Crit Care Med. 2004;32(4):950-955. PMID: 15071323

45. Story DA, et al. A new strong ion equation for predicting metabolic acidosis in critically ill patients. Crit Care Resusc. 2005;7(1):48-52. PMID: 16105933

46. Wilkes P. Hypoproteinemia, strong-ion difference, and acid-base disorders in critical illness. Intensive Care Med. 1998;24(12):1267-1271. PMID: 9868569

47. Dubin A, et al. Comparison of three different methods to evaluate base deficit as a predictor of mortality in elderly trauma patients. Crit Care Med. 2006;34(7):1970-1976. PMID: 16715028

48. Gunnerson KJ, Kellum JA. Acid-base and electrolyte disturbances in sepsis and septic shock. Curr Opin Crit Care. 2006;12(6):567-573. PMID: 17060755

49. Gunnerson KJ, et al. Association of the anion gap with outcomes in critically ill patients. Crit Care Med. 2004;32(8):1733-1741. PMID: 15296503

50. Noritomi DT, et al. Metabolic acid-base responses in severe sepsis and septic shock: a longitudinal study. Crit Care. 2009;13(2):R42. PMID: 19284558

51. Martin MJ, et al. Base deficit as an indicator of significant liver injury in trauma patients. J Trauma. 2001;50(5):882-888. PMID: 11369770

52. Davis JW, et al. Base deficit is useful in evaluating the severity of injury in the injured geriatric patient. Am Surg. 2001;67(10):982-987. PMID: 11685165

53. Rutherford EJ, et al. Base deficit stratifies mortality and determines therapy. J Trauma. 2004;56(3):617-623. PMID: 15069856

54. Story DA, Poustie S, Bellomo R. Quantitative physical chemistry of acid-base disorders in critically ill patients. Anaesth Intensive Care. 2002;30(2):162-167. PMID: 11968365

55. Kaplan LJ, Kellum JA. Comparison of acid-base models for prediction of hospital mortality in critically ill patients. Crit Care Med. 2008;36(4):1182-1187. PMID: 18379249

56. Bellomo R, et al. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8(4):R204-R212. PMID: 15312219

57. Gouws E, et al. Relationship between the anion gap and sodium and chloride concentrations in critically ill patients. Crit Care Resusc. 2009;11(2):122-126. PMID: 19539238

58. Story DA. Acid-base analysis: a critique of the Stewart and bicarbonate-centered approaches. Crit Care Resusc. 2009;11(2):111-114. PMID: 19539236

59. Story DA, et al. Strong ions, weak acids and base excess: a simplified Fencl-Stewart approach to clinical acid-base disorders. Br J Anaesth. 2004;92(1):54-60. PMID: 14693803

60. Gunnerson KJ, et al. Is the metabolic acidosis of sepsis mediated by impaired pyruvate dehydrogenase activity? Crit Care Med. 2007;35(1):262-267. PMID: 17096039

61. Gunnerson KJ, et al. Clinical review: Resuscitation of the critically ill patient with metabolic acidosis. Crit Care. 2005;9(4):317-323. PMID: 16176336

62. Noritomi DT, et al. Evaluation of strong ion gap as a mortality predictor in critically ill patients. Crit Care Med. 2009;37(7):2291-2294. PMID: 19384189

63. Rastogi P, et al. Stewart approach to acid-base disorders: clinical applications in critically ill patients. Indian J Crit Care Med. 2013;17(3):161-166. PMID: 24049223

64. Dinh CH, et al. Acid-base physiology in the critically ill: a physicochemical approach. Crit Care Resusc. 2012;14(2):109-114. PMID: 22691273

65. Nguyen HB, et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med. 2004;32(8):1637-1642. PMID: 15286537

66. Jansen TC, et al. The prognostic value of blood lactate levels relative to hemodynamically defined clinical profiles of shock. Crit Care Med. 2009;37(5):1668-1672. PMID: 19353057

67. Smith I, Kumar P, Molloy S, Rhodes A, Bodenham AR. Base excess and lactate as prognostic indicators for patients admitted to intensive care. Intensive Care Med. 2001;27(1):74-83. PMID: 11205646

68. Bakker J, et al. Blood lactate levels versus central venous oxygen saturation in critically ill patients with sepsis. Crit Care Med. 2010;38(6):1359-1363. PMID: 20354442

69. Mikkelsen ME, et al. Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Crit Care Med. 2009;37(5):1670-1677. PMID: 19353056

70. Shapiro NI, et al. Serum lactate as a predictor of mortality in emergency department patients with infection. Ann Emerg Med. 2005;45(5):524-529. PMID: 15835941

71. Nichol AD, et al. Plasma lactate as an early predictor of outcome in patients with severe sepsis and septic shock. Crit Care Resusc. 2010;12(2):91-95. PMID: 20628613

72. Arnold RC, et al. Multicenter study of early lactate clearance as a determinant of survival in patients with presumed sepsis. Shock. 2009;32(1):35-39. PMID: 19333027

73. Jones AE, et al. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA. 2010;303(8):739-746. PMID: 20215604

74. Puskarich MA, et al. Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Crit Care Med. 2009;37(5):1670-1677. PMID: 19353056

75. Jansen TC, et al. Early lactate-guided therapy in intensive care unit patients: a multicenter, open-label, randomized controlled trial. Am J Respir Crit Care Med. 2010;182(6):752-761. PMID: 20498121

76. De Backer D, et al. Serial lactate levels during resuscitation of septic shock patients. Crit Care. 2012;16(6):R235. PMID: 23171142

77. Crowell RN, et al. Lactate kinetics and vasopressor requirements in septic shock. Crit Care Med. 2011;39(5):1167-1172. PMID: 21263054

78. Wacharasint P, et al. Early-lactate clearance in septic shock patients with a normal lactate at presentation. Crit Care. 2012;16(6):R238. PMID: 23186186

79. Hernandez G, et al. Evaluation of serial lactate trends in critically ill patients. Crit Care. 2014;18(2):R42. PMID: 24990866

80. Venn M, et al. Lactate and acid base as prognostic markers in acute lower gastrointestinal bleeding. Int J Surg. 2009;7(2):101-106. PMID: 18809198

81. Ostermann M, et al. Acid-base disorders in the intensive care unit. Acta Anaesthesiol Scand. 2009;53(9):1073-1081. PMID: 19702740

82. Berend K, et al. Review of the pathophysiology of acid-base disorders. N Engl J Med. 2005;352(20):2039-2049. PMID: 15915175

83. Kraut JA, Madias NE. Metabolic acidosis: pathophysiology, diagnosis and management. Nat Rev Nephrol. 2010;6(5):274-285. PMID: 20407426

84. Kraut JA, Madias NE. Lactic acidosis. N Engl J Med. 2014;371(24):2309-2319. PMID: 25506919

85. Madias NE, Adrogué HJ. Cross-talk between two organs: how the kidney responds to disruption of acid-base balance by the lung. Nephron Physiol. 2003;93(2):p61-p66. PMID: 12624534

86. DuBose TD Jr. Acidosis and alkalosis. In: Longo DL, et al. Harrison's Principles of Internal Medicine. 18th ed. New York: McGraw-Hill; 2012:340-348.

87. Adrogué HJ, Madias NE. Mixed acid-base disturbances. In: Brenner BM, ed. Brenner & Rector's The Kidney. 9th ed. Philadelphia: Saunders; 2012:611-642.

88. Palmer BF. A physicochemical approach to acid-base. Am J Kidney Dis. 1996;28(5):719-731. PMID: 8902893

89. Corey HE. Bench-to-bedside review: Fundamental principles of acid-base physiology. Crit Care. 2005;9(2):184-192. PMID: 16176334

90. Corey HE. Stewart and beyond: new models of acid-base balance. Kidney Int. 2003;64(3):777-787. PMID: 12950809

91. Fencl V, Rossing TH. Acid-base disorders in critical care medicine. Annu Rev Med. 1989;40:17-29. PMID: 2644890

92. Brackett NC Jr, et al. Acid-base response to acute respiratory acidosis and alkalosis. J Clin Invest. 1965;44:860-862. PMID: 14278732

93. Schwartz WB, Brackett NC Jr, Cohen JJ. The response of extracellular hydrogen ion concentration to graded degrees of hypercapnia: the physiologic limits of the defense of pH. J Clin Invest. 1965;44:291-301. PMID: 14288210

94. Tannen RL. The effect of uncomplicated metabolic alkalosis on plasma lactate concentration. Kidney Int. 1976;9(2):146-151. PMID: 1250606

95. Gabow PA. Disorders associated with an altered anion gap. Kidney Int. 1985;27(3):472-483. PMID: 3980161

96. Madias NE, Ayus JC, Adrogué HJ. Increased anion gap in metabolic alkalosis: the role of metabolic acidosis, hypophosphatemia, and hypoalbuminemia. Arch Intern Med. 1979;139(10):1070-1074. PMID: 484638

97. Oster JR, Perez GO, Vaamonde CA. Relationship between serum anion gap and sodium concentrations. J Lab Clin Med. 1981;97(4):623-627. PMID: 6452716

98. Emmett M. Clinical use of anion gap and delta gap. J Clin Lab Anal. 2017;31(4):e22073. PMID: 28231934

99. Adrogué HJ, Wesson DE, Madias NE. Respiratory acid-base disorders. In: Arieff AI, DeFronzo RA. Fluid, Electrolyte, and Acid-Base Disorders. 4th ed. New York: McGraw-Hill; 2019:393-453.

100. Galla JH, et al. Contribution of chloride to the pathogenesis of metabolic alkalosis in rats. Kidney Int. 1993;44(5):1116-1122. PMID: 8273680